PALONOSETRON DR REDDY'S palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial Austrália - inglês - Department of Health (Therapeutic Goods Administration)

palonosetron dr reddy's palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial

dr reddys laboratories australia pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide - palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.

SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 900 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 1128.6 microgram (equivalent: pasireotide, qty 900 microgram) - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; tartaric acid - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 300 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 376.2 microgram (equivalent: pasireotide, qty microgram) - injection, solution - excipient ingredients: water for injections; mannitol; tartaric acid; sodium hydroxide - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

signifor pasireotide 600 microgram/1 ml (as diaspartate) solution for injection ampoule

recordati rare diseases australia pty ltd - pasireotide diaspartate, quantity: 752.4 microgram (equivalent: pasireotide, qty 600 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; tartaric acid; mannitol - the treatment of adult patients with cushing?s disease for whom surgery is not an option or for whom surgery has failed.

NEUROLITE bicisate dihydrochloride 0.9mg/mL kit for the preparation of technetium [99Tc] bicisate Austrália - inglês - Department of Health (Therapeutic Goods Administration)

neurolite bicisate dihydrochloride 0.9mg/ml kit for the preparation of technetium [99tc] bicisate

global medical solutions australia pty limited t/a radpharm scientific - bicisate dihydrochloride, quantity: 0.9 mg - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; monobasic sodium phosphate; water for injections - [99mtc]-bicisate scintigraphy is indicated in the evaluation and localisation of regional perfusion abnormalities in adult patients with the central nervous system disorders of stroke and dementia.

First aid kit, non-medicated, single-use Austrália - inglês - Department of Health (Therapeutic Goods Administration)

first aid kit, non-medicated, single-use

medical solution aust pty ltd - 44047 - first aid kit, non-medicated, single-use - first aid kit single use for wound care, non medicated

CIPLA ISOPRENALINE isoprenaline hydrochloride 1.0 mg/5 mL injection solution ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

cipla isoprenaline isoprenaline hydrochloride 1.0 mg/5 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

CIPLA ISOPRENALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule Austrália - inglês - Department of Health (Therapeutic Goods Administration)

cipla isoprenaline isoprenaline hydrochloride 0.2 mg/1 ml injection solution ampoule

cipla australia pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections - cipla isoprenaline is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 special warnings and precautions for use).

Surgical/medical respirator, single-use Austrália - inglês - Department of Health (Therapeutic Goods Administration)

surgical/medical respirator, single-use

texas medical technology (australia) pty ltd - 57794 - surgical/medical respirator, single-use - a single-use niosh-approved n95 particulate filtering facepiece respirators, also used as surgical respirator designed to be placed over the nose and mouth of a member of the medical staff and/or general public to permit normal breathing while protecting the wearer from exposure to pathogenic biological airborne particulates during a public health medical emergency.

ClindaTech Clindamycin hydrochloride 10mg/mL solution bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

clindatech clindamycin hydrochloride 10mg/ml solution bottle

inova pharmaceuticals (australia) pty ltd - clindamycin hydrochloride, quantity: 10 mg/ml - solution - excipient ingredients: dioctyl malate; purified water; ethanol - clindtech solution is indicated for the topical treatment of acne vulgaris, particularly forms in which comedones, papules and pastules predominate.